Epic Systems expands EHR market share lead over Oracle Health

Epic Systems expands EHR market share lead over Oracle Health


The eponymous sign outside Epic headquarters in Verona, Wisconsin.

Source: Yiem via Wikipedia CC

Epic Systems, the biggest electronic health records (EHR) vendor, notched its largest ever net gain in hospital market share on record in 2024, widening its lead over rival Oracle, according to a report from Klas Research on Wednesday.

Epic added a total of 176 facilities and 29,399 beds in 2024, while Oracle lost 74 sites and 17,232 beds during the same period, the report said. For the first time ever, Oracle declined to share a list of new contracts with Klas, a health-care IT research foundation. Klas said it estimated Oracle’s market share.

“Beyond strictly technological considerations, Epic’s reputation for customer partnership has brought them to the forefront of most EHR considerations,” the report said.

Oracle and Epic didn’t immediately respond to CNBC’s request for comment.

EHRs are digital versions of a patient’s medical history that are updated by doctors and nurses. The software sits at the center of the modern U.S. health-care system. Oracle became the second-largest vendor behind privately held Epic in 2022 by acquiring the medical records giant Cerner for roughly $28 billion.

Health-care organizations have cited “poor partnership and a lack of follow-through on promises” as their primary concerns with Oracle, Klas said. But there’s a sense of “cautious optimism” following some of the company’s recent technological developments, including new artificial intelligence features and the brand-new EHR Oracle announced in October.

Based on recent comments from Oracle founder Larry Ellison, his company is in a favorable spot.

Ellison spent a lot of time on the subject in fireside chats at the company’s annual Oracle Health Summit in March. And on Oracle’s quarterly call with investors in September, Ellison said his company’s EHR is equipped with AI capabilities like transcription and order distribution that make it unique.

“Our user interface is so different than Epic’s,” he said.

In a blog post in May Ken Glueck, an executive vice president at Oracle, went after Epic, calling founder and CEO Judy Faulkner the “single biggest obstacle to EHR interoperability,” a term for how different software systems exchange information.

But Oracle’s EHR software has been marred by outages and rocky deployments in recent years.

Oracle engineers mistakenly caused a five-day software outage at several Community Health Systems hospitals that was just cleared up this week. The facilities had to activate downtime procedures and to temporarily return to paper-based patient records.

“Over the last decade, Epic has been the only vendor chosen by large health systems making go-forward EHR decisions, leading to their consistent growth in market share,” the Klas report said. 

WATCH: Oracle misses on quarterly results, raises dividend by 25%

Oracle misses on quarterly results, raises dividend by 25%



Source

Sarepta shares plunge 40% as future of its gene therapy appears at risk
Health

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The […]

Read More
Trump diagnosed with common vein condition after ankle swelling raises concerns
Health

Trump diagnosed with common vein condition after ankle swelling raises concerns

First Lady Melania Trump, President Donald Trump, FIFA President Gianni Infantino and his wife, Leena Al Ashqar, attend the FIFA Club World Cup 2025 final football match between England’s Chelsea and France’s Paris Saint-Germain at MetLife Stadium in East Rutherford, New Jersey, July 13, 2025. Charly Triballeau | AFP | Getty Images President Donald Trump […]

Read More
Abbott stock fell victim to an old earnings season truth: It’s all about the guidance
Health

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results, […]

Read More